We posit that the early activation of the antisteatogenic adiponectin-LKB1-AMPK-FOXO-signaling axis effectively protects the CHIP−/−-liver from aggravated NAFLD/NASH-manifestations. The gene discussed is ADIPOQ; the disease is metabolic dysfunction-associated steatohepatitis.